Table 3. Guidelines for Assessment of Vitamin B12 Levels.
| Guideline | Whom to Test? | How Frequently? | Overall Recommendation |
|---|---|---|---|
| BC Guidelines and Protocols Advisory Committee, 2012 (19) | Patients with unexplained neurologic symptoms (paresthesia, numbness, poor motor coordination, memory lapses) Patients with acrocytic anemia or macrocytosis |
Not reported | Routine screening for vitamin B12 deficiency is not recommended |
| Smellie et al, 2005 (20) | Patients with acrocytic anemia Patients with acrocytosis Patients with specific neurocognitive abnormalities |
”There is no obvious merit in repeating vitamin B12 measurements unless lack of compliance is suspected or anemia recurs” | Not reported |
| Andres et al, 2004 (21) | Elderly patients with malnutrition All patients in institutions and psychiatric hospitals All patients with hematologic or neurocognitive manifestations of vitamin B12 deficiency |
Not reported | Not reported |